Cyclo Therapeutics reports Q2  net loss approximately $6M
PremiumThe FlyCyclo Therapeutics reports Q2 net loss approximately $6M
1M ago
CYTH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CYTH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Cyclo Therapeutics granted patent by European Patent Office
Premium
The Fly
Cyclo Therapeutics granted patent by European Patent Office
2M ago
Starbucks downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
PremiumThe FlyStarbucks downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
5M ago
Cyclo Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Cyclo Therapeutics initiated with a Buy at H.C. Wainwright
5M ago
Cyclo Therapeutics initiated with a Buy at Ascendiant
Premium
The Fly
Cyclo Therapeutics initiated with a Buy at Ascendiant
5M ago
One new option listing and one option delisting on December 29th
PremiumThe FlyOne new option listing and one option delisting on December 29th
9M ago
Cyclo Therapeutics closes AMT merger, cash runway extended into 2H
Premium
The Fly
Cyclo Therapeutics closes AMT merger, cash runway extended into 2H
9M ago
CYTH Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CYTH Upcoming Earnings Report: What to Expect?
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100